Kundu Sourav bought NXTC
March 29, 2024 · Form 4 insider transaction
Kundu Sourav bought 52,900 shares of NextCure, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
52,900
Price
$0.00
Total value
N/A
InsiderKundu Sourav
RoleOfficer
CompanyNextCure, Inc. (NXTC)
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 29, 2024
Filing dateApril 2, 2024
Shares owned after52,900
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests in full on the one year anniversary of the grant, March 29, 2025.